Organon (OGN) Common Equity (2020 - 2026)
Organon (OGN) posted quarterly Common Equity of $1.0 billion for Q2 2026, up 37.24% year-over-year from $733.0 million in Q2 2025, and up 11.41% on a QoQ basis from $903.0 million in Q1 2026.
Organon (OGN) Common Equity (2020 - 2026) Analysis & Trends
Organon has reported Common Equity for 7 years, with the latest figure at $1.0 billion in Q2 2026.
- Common Equity for Q2 2026 came in at $1.0 billion, up 37.24% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.0 billion (up 37.24% YoY), and the FY2025 annual result was $752.0 million, up 59.32% from the prior year.
- Common Equity grew to $1.0 billion in Q2 2026, from $903.0 million in the prior quarter.
- Over five years, Common Equity peaked at $1.0 billion in Q2 2026 and troughed at -$1.2 billion in Q1 2022.
- A 5-year average of -$16.5 million and a median of $96.0 million in 2024 frame the typical range for Common Equity.
- The widest annual swing landed in 2022, when Common Equity sank 126.47%; it then soared 1029.17% in 2025.
- A 5-year view of Common Equity shows it stood at -$892.0 million in 2022, then surged by 92.15% to -$70.0 million in 2023, then surged by 774.29% to $472.0 million in 2024, then soared by 59.32% to $752.0 million in 2025, then soared by 33.78% to $1.0 billion in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $1.0 billion in Q2 2026, $903.0 million in Q1 2026, and $752.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.58 Bn | 627.82 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 466.01 Bn | 459.44 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 375.19 Bn | 368.05 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 300.09 Bn | 292.40 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 256.64 Bn | 251.74 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 235.38 Bn | 221.39 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 180.78 Bn | 177.60 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Gsk | 105.22 Bn | 101.06 Bn | 8.24 Bn | 23.05 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 903.00 Mn |
| Dec 31, 2025 | 752.00 Mn |
| Sep 30, 2025 | 906.00 Mn |
| Jun 30, 2025 | 733.00 Mn |
| Mar 31, 2025 | 542.00 Mn |
| Dec 31, 2024 | 472.00 Mn |
| Sep 30, 2024 | 493.00 Mn |
| Jun 30, 2024 | 144.00 Mn |
| Mar 31, 2024 | 48.00 Mn |
| Dec 31, 2023 | -70.00 Mn |
| Sep 30, 2023 | -589.00 Mn |
| Jun 30, 2023 | -555.00 Mn |
| Mar 31, 2023 | -737.00 Mn |
| Dec 31, 2022 | -892.00 Mn |
| Sep 30, 2022 | -1.07 Bn |
| Jun 30, 2022 | -1.14 Bn |
| Mar 31, 2022 | -1.25 Bn |
| Dec 31, 2021 | -1.51 Bn |
| Sep 30, 2021 | -1.62 Bn |